{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:43:27Z","timestamp":1774917807167,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222186","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T17:37:25Z","timestamp":1568223445000},"page":"e0222186","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Competing priorities and second chances - A qualitative exploration of prisoners\u2019 journeys through the Hepatitis C continuum of care"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-9596","authenticated-orcid":true,"given":"Desmond","family":"Crowley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Claire","family":"Van Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"pone.0222186.ref001","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis","volume":"58","author":"S Larney","year":"2013","journal-title":"Hepatology"},{"key":"pone.0222186.ref002","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"K Dolan","year":"2016","journal-title":"Lancet"},{"key":"pone.0222186.ref003","article-title":"Prisons and health","volume":"207","author":"World Health Organisation","year":"2014"},{"key":"pone.0222186.ref004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jech.2006.051599","article-title":"Correlates of hepatitis C virus seropositivity in prison inmates: A meta-analysis","volume":"62","author":"MF Vescio","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"pone.0222186.ref005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurpub\/ckv133","article-title":"Routine testing for blood-borne viruses in prisons: A systematic review","volume":"25","author":"C Rumble","year":"2015","journal-title":"Eur J Public Health"},{"key":"pone.0222186.ref006","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection","volume":"65","author":"H Midgard","year":"2016","journal-title":"J Hepatol"},{"key":"pone.0222186.ref007","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/COH.0000000000000179","article-title":"The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)","volume":"10","author":"NK Martin","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0222186.ref008","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users","volume":"24","author":"D Swan","year":"2010","journal-title":"A Qualitative Exploration. AIDS Patient Care STDS"},{"key":"pone.0222186.ref009","article-title":"Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research","volume":"25","author":"L Jones","year":"2014"},{"key":"pone.0222186.ref010","doi-asserted-by":"crossref","first-page":"e87564","DOI":"10.1371\/journal.pone.0087564","article-title":"A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners","volume":"9","author":"L Yap","year":"2014","journal-title":"PLoS One"},{"key":"pone.0222186.ref011","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/S0168-8278(17)30899-1","article-title":"The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments","volume":"66","author":"B Hajarizadeh","year":"2017","journal-title":"J Hepatol"},{"key":"pone.0222186.ref012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cld.626","article-title":"Treatment of HCV in persons who inject drugs: Treatment as prevention","volume":"9","author":"J Grebely","year":"2017","journal-title":"Clin Liver Dis"},{"key":"pone.0222186.ref013","unstructured":"Public Health England. Hepatitis C in the UK 2017 Report. 2017."},{"key":"pone.0222186.ref014","volume-title":"Global Hepatitis Report 2017","author":"WHO","year":"2017"},{"key":"pone.0222186.ref015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/add.13764","article-title":"Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?","volume":"112","author":"I Gountas","year":"2017","journal-title":"Addiction"},{"key":"pone.0222186.ref016","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugpo.2017.08.001","article-title":"Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy","volume":"47","author":"J Grebely","year":"2017","journal-title":"Int J Drug Policy"},{"key":"pone.0222186.ref017","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm","volume":"113","author":"A Cuadrado","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"pone.0222186.ref018","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41395-018-0201-x","article-title":"Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment","volume":"113","author":"JS Redman","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"pone.0222186.ref019","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciy210","article-title":"Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project","volume":"67","author":"SR Bartlett","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pone.0222186.ref020","unstructured":"Irish Prison Service. Irish Prison Service Annual Report 2017. Dublin: 2017. https:\/\/www.irishprisons.ie\/wp-content\/uploads\/documents_pdf\/IPS-annualreport-2017.pdf."},{"key":"pone.0222186.ref021","article-title":"Study on the prevalence of drug use, including intravenous drug use, and blood-borne viruses among the Irish prisoner population","author":"A Drummond","year":"2014","journal-title":"Dublin: National Advisory Committee on Drugs and Alcohol"},{"key":"pone.0222186.ref022","unstructured":"Department of Health. Hepatitis C Screening (NCEC National Clinical Guideline No. 15). Dublin: 2017."},{"key":"pone.0222186.ref023","unstructured":"Health Service Executive. National Hepatitis C Treatment Programme\u2014Ireland\u2019s Health Service. Health Service Executive; 2018."},{"key":"pone.0222186.ref024","unstructured":"Health Service Executive. National Hepatitis C Strategy 2011\u20132014. Dublin: 2012."},{"key":"pone.0222186.ref025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugpo.2018.07.015","article-title":"Caring and curing: Considering the effects of hepatitis C pharmaceuticalisation in relation to non-clinical treatment outcomes","volume":"60","author":"M Harris","year":"2018","journal-title":"Int J Drug Policy"},{"key":"pone.0222186.ref026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors","volume":"10","author":"M Harris","year":"2013","journal-title":"Harm Reduct J"},{"key":"pone.0222186.ref027","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1186\/s12889-016-3671-z","article-title":"Facilitators of HCV treatment adherence among people who inject drugs: A systematic qualitative review and implications for scale up of direct acting antivirals","volume":"16","author":"ZC Rich","year":"2016","journal-title":"BMC Public Health"},{"key":"pone.0222186.ref028","article-title":"Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective\u2014A qualitative exploration","volume":"6","author":"D Crowley","year":"2018","journal-title":"Heal Justice"},{"key":"pone.0222186.ref029","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2458-7-98","article-title":"\u2018I just keep thinking I haven\u2019t got it because I\u2019m not yellow\u2019: A qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners","volume":"7","author":"FM Khaw","year":"2007","journal-title":"BMC Public Health"},{"key":"pone.0222186.ref030","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jvh.12987","article-title":"Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison","volume":"25","author":"L Lafferty","year":"2018","journal-title":"J Viral Hepat"},{"key":"pone.0222186.ref031","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/17474124.2018.1424541","article-title":"Hepcare Europe\u2014bridging the gap in the treatment of hepatitis C: study protocol","volume":"12","author":"D Swan","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"pone.0222186.ref032","author":"BG Glaser","year":"1967"},{"key":"pone.0222186.ref033","doi-asserted-by":"crossref","DOI":"10.5042\/daat.2010.0254","article-title":"Maze and minefield: a grounded theory of opiate self-detoxification in rural Ireland","author":"A McDonnell","year":"2010"},{"key":"pone.0222186.ref034","unstructured":"European Centre for Disease Prevention and Control and the European Monitoring Centre for Drugs and Drug Addiction. Systematic review on active case finding of communicable diseases in prison settings. Stockholm: 2017. doi: 10.2900\/348536"},{"key":"pone.0222186.ref035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/hex.12590","article-title":"Improving the quality of prison research: A qualitative study of ex-offender service user involvement in prison suicide prevention research","volume":"21","author":"YF Awenat","year":"2018","journal-title":"Heal Expect"},{"key":"pone.0222186.ref036","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.drugpo.2014.01.011","article-title":"How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting","volume":"25","author":"C Treloar","year":"2014","journal-title":"Int J Drug Policy"},{"key":"pone.0222186.ref037","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12889-015-1584-x","article-title":"A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons","volume":"15","author":"AM Bagnall","year":"2015","journal-title":"BMC Public Health"},{"key":"pone.0222186.ref038","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jvh.12513","article-title":"Finding the undiagnosed: A qualitative exploration of hepatitis C diagnosis delay in the United Kingdom","volume":"23","author":"M Harris","year":"2016","journal-title":"J Viral Hepat"},{"key":"pone.0222186.ref039","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"RH Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0222186.ref040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0973-6247.126683","article-title":"Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays","volume":"8","author":"M Bajpai","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"pone.0222186.ref041","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordhb\/9780195393781.013.0021","volume-title":"Crime, Incarceration, and Poverty","author":"S Raphael","year":"2012"},{"key":"pone.0222186.ref042","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis","volume":"391","author":"RW Aldridge","year":"2018","journal-title":"Lancet"},{"key":"pone.0222186.ref043","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjms.2016.05.020","article-title":"Infectious Diseases and the Criminal Justice System","volume":"352","author":"AE Nijhawan","year":"2016","journal-title":"Am J Med Sci"},{"key":"pone.0222186.ref044","article-title":"Public health guidance on active case finding of communicable diseases in prison settings Prevention and control of communicable diseases in prison settings","author":"Centre for Disease Prevention E","year":"2018","journal-title":"Stockholm and Lisbon"},{"key":"pone.0222186.ref045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","article-title":"Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis c in the custodial setting","volume":"56","author":"AR Lloyd","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pone.0222186.ref046","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(16)30208-0","article-title":"Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses","volume":"16","author":"K Zhou","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"pone.0222186.ref047","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1037\/0003-066X.47.9.1102","article-title":"In search of how people change. Applications to addictive behaviors","volume":"47","author":"JO Prochaska","year":"1992","journal-title":"Am Psychol"},{"key":"pone.0222186.ref048","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3109\/10826084.2016.1161054","article-title":"Clinicians\u2019 Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs","volume":"51","author":"AK Asher","year":"2016","journal-title":"Subst Use Misuse"},{"key":"pone.0222186.ref049","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-0406","article-title":"Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States","volume":"163","author":"S Barua","year":"2015","journal-title":"Ann Intern Med"},{"key":"pone.0222186.ref050","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/hep.30303","article-title":"Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States","volume":"69","author":"H Park","year":"2019","journal-title":"Hepatology"},{"key":"pone.0222186.ref051","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12889-018-5765-2","article-title":"Participant, peer and PEEP: Considerations and strategies for involving people who have used illicit substances as assistants and advisors in research","volume":"18","author":"AM Greer","year":"2018","journal-title":"BMC Public Health"},{"key":"pone.0222186.ref052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2017.08.004","article-title":"\u2018Beyond the willing & the waiting\u2019\u2014The role of peer-based approaches in hepatitis C diagnosis & treatment","volume":"50","author":"C Henderson","year":"2017","journal-title":"Int J Drug Policy"},{"key":"pone.0222186.ref053","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/add.13783","article-title":"Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland","volume":"112","author":"J Stone","year":"2017","journal-title":"Addiction"},{"key":"pone.0222186.ref054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/eurpub\/ckv183","article-title":"Addressing the challenges of chronic viral infections and addiction in prisons: The PRODEPIST study","volume":"26","author":"C Jacomet","year":"2016","journal-title":"Eur J Public Health"},{"key":"pone.0222186.ref055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: A systematic review","volume":"107","author":"D Hedrich","year":"2012","journal-title":"Addiction"},{"key":"pone.0222186.ref056","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"IA Binswanger","year":"2013","journal-title":"Ann Intern Med"},{"key":"pone.0222186.ref057","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/add.13803","article-title":"High risk of overdose death following release from prison: variations in mortality during a 15-year observation period","volume":"112","author":"A Bukten","year":"2017","journal-title":"Addiction"},{"key":"pone.0222186.ref058","article-title":"Competing priorities that rival health in adults on probation in Rhode Island: Substance use recovery, employment, housing, and food intake","volume":"18","author":"KR Dong","year":"2018","journal-title":"BMC Public Health"},{"key":"pone.0222186.ref059","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-016-0487-5","article-title":"Exploring levers and barriers to accessing primary care for marginalised groups and identifying their priorities for primary care provision: A participatory learning and action research study","volume":"15","author":"P O\u2019Donnell","year":"2016","journal-title":"Int J Equity Health"},{"key":"pone.0222186.ref060","unstructured":"How can health services effectively meet the health needs of homeless people? n.d."},{"key":"pone.0222186.ref061","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1745-7599.2008.00371.x","article-title":"Healthcare experiences of the homeless","volume":"21","author":"B Nickasch","year":"2009","journal-title":"J Am Acad Nurse Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:03:25Z","timestamp":1589036605000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222186"}},"subtitle":[],"editor":[{"given":"Heidi E.","family":"Drummer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222186","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]}}}